14C-對氨基馬尿酸(14C-PAH)、hOAT3介導(dǎo)的3H-硫酸雌酮銨(3H-ES)、hOATP1B1介導(dǎo)的3H-ES、hOATP1B3介導(dǎo)的3H-雌二醇葡糖苷酸(3H-EG)、hOCT1介導(dǎo)的14C-溴化四乙胺(14C-TEA)、hOCT2介導(dǎo)的14C-TEA、hBCRP介導(dǎo)的3H-ES、MDR1介導(dǎo)的3H-地高辛(3H-Digoxin)、以及hBSEP介導(dǎo)的3H-牛黃膽酸鹽(3H-TCA)轉(zhuǎn)運活性的影響,計算淫羊藿苷元對不同轉(zhuǎn)運蛋白的抑制作用的半數(shù)抑制濃度(IC50)。結(jié)果 與對照組比較,淫羊藿苷元0.3~10 μmol/L濃度對OAT3轉(zhuǎn)運活性發(fā)揮顯著抑制作用(P<0.05),0.1~10 μmol/L對P-gp有顯著抑制作用;1~10 μmol/L濃度對OATP1B3和BCRP轉(zhuǎn)運活性有顯著抑制作用(P<0.05);3~10 μmol/L濃度對和OATP1B1轉(zhuǎn)運活性有顯著抑制作用(P<0.05);對OAT3和BCRP轉(zhuǎn)運活性的IC50分別為4.97和8.15 μmol/L;對OAT1B1、OATP1B3、OCT2和P-gp的IC50均大于10 μmol/L,對OAT1、OCT1和BSEP轉(zhuǎn)運活性無明顯影響。結(jié)論 淫羊藿苷元對藥物轉(zhuǎn)運體OAT3和BCRP的抑制作用相對較強,對OAT1B1、OATP1B3、OCT2和P-gp也具有一定的抑制作用,對OAT1、OCT1和BSEP無顯著抑制作用。;Objective To research the inhibition of anhydroicaritin to the important clinical transporters including OAT1, OAT3, OATP1B1, OATP1B3, OCT1, OCT2, BCRP, BSEP, and P-gp. Method The transgenic cell lines overexpressing OAT1, OAT3, OATP1B1, OATP1B3, OCT1, OCT2, BCRP, BSEP, and P-gp were constructed, and the inhibition of anhydroicaritin (0, 0.03, 0.10, 0.30, 1.00, 3.00, and 10.00 μmol/L) on the different transporters were evaluated by the effects of anhydroicaritin on transport activity of the radiolabeled substrates of 14C-PAH, 3H-ES, 3H-ES, 3H-EG, 14C-TEA, 14C-TEA, 3H-ES, 3H-Digoxin, 3H-TCA mediated by hOAT1, hOAT3, OATP1B, hOATP1B3, hOCT1, hOCT2, hBCRP, MDR1,and hBSEP, respectively. The half maximal inhibitory concentration (IC50) of anhydroicartin to every transporters were calculated by the software Prism 5.0. Result Compared with control group, anhydroicaritin of 0.3 - 10 mol/L concentration had significant inhibitory effects on the transport activity of OAT3, BCRP, and OATP1B3 (P<0.05), and concentration of 0.1~10 and 1~10 μmol/L significantly inhibited the P-gp and OATP1B1 transport activity (P<0.05). The IC50 of anhydroicaritin to OAT3 and BCRP transport activity was 4.97 and 8.15 mol/L, respectively, and IC50 of OAT1B1, OATP1B3, OCT2, and P-gp were more than 10 μmol/L, and with no obvious effects on the transport activity of OAT1, OCT1, and BSEP. Conclusion Anhydroicaritin showed strong inhibition to OAT3 and BCRP, and showed certain inhibition to OATP1B1, OATP1B3, OCT2, and P-gp inordinately, but no inhibition to OAT1, OCT1, and BSEP."/> 50"/>

醉酒后少妇被疯狂内射视频,一本色道久久综合一,在线天堂新版资源www在线下载,中文字幕乱人伦高清视频,中字幕视频在线永久在线观看免费

首頁 > 過刊瀏覽>2018年第41卷第6期 >2018,41(6):986-991. DOI:10.7501/j.issn.1674-6376.2018.06.009
上一篇 | 下一篇

淫羊藿苷元對臨床重要藥物轉(zhuǎn)運體抑制作用研究

Inhibition effects of anhydroicaritin on important clinical drug transporters

發(fā)布日期:2018-06-05
您是第位訪問者
藥物評價研究 ® 2025 版權(quán)所有
技術(shù)支持:北京勤云科技發(fā)展有限公司
津備案:津ICP備13000267號 互聯(lián)網(wǎng)藥品信息服務(wù)資格證書編號:(津)-非經(jīng)營性-2015-0031